PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
PVCT was delisted on the 13th of October, 2016.
4 hedge funds and large institutions have $9K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0% more capital invested
Capital invested by funds: $9K → $9K ($0)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIA
LBMC Investment Advisors
Brentwood,
Tennessee
|
+$1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BO
BRR OpCo
Columbus,
Ohio
|
-$2K |
PVCT Hedge Fund Activity: Q1 2019 in Review
4 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q1 2019, worth a combined $9K — unchanged from a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PVCT and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was LBMC Investment Advisors, opening a new position worth an estimated $1K. The largest seller was BRR OpCo, exiting entirely with an estimated $2K sold.
- 4 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q1 2019, down from 5 in Q4 2018.
- Funds reported $9K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q1 2019, unchanged quarter-over-quarter.
- 1 fund opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q1 2019 and 2 closed out, a net change of -1 holder.
- The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) buyer in Q1 2019 was LBMC Investment Advisors, an estimated $1K added.
- The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) seller in Q1 2019 was BRR OpCo, an estimated $2K sold.
Based on aggregated 13F filings for Q1 2019.